TWD 18.9
(0.8%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 939.94 Million TWD | 8.5% |
2022 | 866.27 Million TWD | 5.12% |
2021 | 824.1 Million TWD | -4.85% |
2020 | 866.11 Million TWD | -1.35% |
2019 | 877.93 Million TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 207.43 Million TWD | 0.0% |
2024 Q1 | 207.43 Million TWD | -16.15% |
2023 Q2 | 222.59 Million TWD | 0.0% |
2023 FY | 939.94 Million TWD | 8.5% |
2023 Q4 | 247.37 Million TWD | 0.0% |
2023 Q3 | 247.37 Million TWD | 11.14% |
2023 Q1 | 222.59 Million TWD | -10.26% |
2022 Q3 | 248.03 Million TWD | 0.0% |
2022 FY | 866.27 Million TWD | 5.12% |
2022 Q4 | 248.03 Million TWD | 0.0% |
2021 FY | 824.1 Million TWD | -4.85% |
2020 FY | 866.11 Million TWD | -1.35% |
2019 FY | 877.93 Million TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Allied Biotech Corporation | 720.43 Million TWD | -30.47% |
GeneFerm Biotechnology Co., Ltd. | 793.77 Million TWD | -18.415% |
Easywell Biomedicals, Inc. | 271.62 Million TWD | -246.041% |
TTY Biopharm Company Limited | 5.5 Billion TWD | 82.927% |
Synmosa Biopharma Corporation | 5.14 Billion TWD | 81.715% |
Orient EuroPharma Co., Ltd. | 4.59 Billion TWD | 79.53% |
Center Laboratories, Inc. | 1.39 Billion TWD | 32.573% |
Tien Liang BioTech Co., Ltd. | 459.99 Million TWD | -104.339% |
Orient Pharma Co., Ltd. | 889.91 Million TWD | -5.622% |
InnoPharmax Inc. | 46.07 Million TWD | -1940.119% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 606.71 Million TWD | -54.925% |
Excelsior Biopharma Inc. | 771.56 Million TWD | -21.824% |
DV Biomed Co., Ltd. | 1.53 Billion TWD | 38.899% |
Foresee Pharmaceuticals Co., Ltd. | 195.03 Million TWD | -381.929% |
Handa Pharmaceuticals, Inc. | 1.1 Billion TWD | 15.039% |
UniPharma Co., Ltd. | 103.22 Million TWD | -810.604% |
Alar Pharmaceuticals Inc. | 469.27 Million TWD | -100.298% |
Winston Medical Supply Co., Ltd. | 709.07 Million TWD | -32.559% |
Mercury Biopharmaceutical Corporation | 1.03 Million TWD | -90891.675% |
Bioray Biotech Co., Ltd | 191.83 Million TWD | -389.988% |
TSH Biopharm Corporation Limited | 810.91 Million TWD | -15.911% |